Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Gen Hosp Psychiatry. 2017 Sep;48:1-19. doi: 10.1016/j.genhosppsych.2017.06.011. Epub 2017 Jun 24.
Catatonia is a commonly encountered syndrome, affecting 10-20% of various psychiatric populations and carrying significant medical co-morbidities. However, there are few established alternative treatment strategies when benzodiazepines are ineffective and electroconvulsive therapy is unavailable.
The authors systematically review evidence for alternative treatment strategies for catatonia using Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
The authors conducted a search of PubMed database from 1983 to August 2016 to identify articles. Eligible reports presented cases involving treatment of catatonia using modalities other than benzodiazepines or electroconvulsive therapy.
The authors identified 72 articles, comprising 98 individual cases. N-methyl-d-aspartate-receptor antagonists, anti-epileptic drugs, and atypical antipsychotic agents appeared to have the largest number of reports supporting their effectiveness and safety in treating catatonia patients.
Based on the case report literature, the authors propose an updated algorithm for catatonia treatment in cases where benzodiazepines fail and electroconvulsive therapy is not available.
紧张症是一种常见的综合征,影响 10-20%的各种精神科人群,并伴有显著的合并症。然而,当苯二氮䓬类药物无效且无电抽搐治疗时,很少有既定的替代治疗策略。
作者使用系统评价和荟萃分析的首选报告项目(PRISMA)指南系统地回顾了紧张症替代治疗策略的证据。
作者对从 1983 年到 2016 年 8 月的 PubMed 数据库进行了搜索,以确定文章。合格的报告提出了使用除苯二氮䓬类药物或电抽搐治疗以外的方式治疗紧张症的病例。
作者确定了 72 篇文章,包括 98 个单独的病例。N-甲基-D-天冬氨酸受体拮抗剂、抗癫痫药物和非典型抗精神病药物似乎有最多的报告支持它们在治疗紧张症患者中的有效性和安全性。
根据病例报告文献,作者提出了一种更新的苯二氮䓬类药物治疗失败且无电抽搐治疗时紧张症治疗的算法。